Literature DB >> 11036119

Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease.

B Lindahl1, H Toss, A Siegbahn, P Venge, L Wallentin.   

Abstract

BACKGROUND: In patients with unstable coronary artery disease, there is a relation between the short-term risk of death and blood levels of troponin T (a marker of myocardial damage) and C-reactive protein and fibrinogen (markers of inflammation). Using information obtained during an extension of the follow-up period in the Fragmin during Instability in Coronary Artery Disease trial, we evaluated the usefulness of troponin T, C-reactive protein, and fibrinogen levels and other indicators of risk as predictors of the long-term risk of death from cardiac causes.
METHODS: Levels of C-reactive protein and fibrinogen at enrollment and the maximal level of troponin T during the first 24 hours after enrollment were analyzed in 917 patients included in a clinical trial of low-molecular-weight heparin in unstable coronary artery disease. The patients were followed for a mean of 37.0 months (range, 1.6 to 50.6).
RESULTS: During follow-up, 1.2 percent of the 173 patients with maximal blood troponin T levels of less than 0.06 microg per liter died of cardiac causes, as compared with 8.7 percent of the 367 patients with levels of 0.06 to 0.59 microg per liter and 15.4 percent of the 377 patients with levels of at least 0.60 microg per liter (P=0.007 and P=0.001, respectively). The rates of death from cardiac causes were 5.7 percent among the 314 patients with blood C-reactive protein levels of less than 2 mg per liter, 7.8 percent among the 294 with levels of 2 to 10 mg per liter, and 16.5 percent among the 309 with levels of more than 10 mg per liter (P=0.29 and P=0.001, respectively). The rates of death from cardiac causes were 5.4 percent among the 314 patients with blood fibrinogen levels of less than 3.4 g per liter, 12.0 percent among the 300 with levels of 3.4 to 3.9 g per liter, and 12.9 percent among the 303 with levels of at least 4.0 g per liter (P=0.004 and P=0.69, respectively). In a multivariate analysis, levels of troponin T and C-reactive protein were independent predictors of the risk of death from cardiac causes.
CONCLUSIONS: In unstable coronary artery disease, elevated levels of troponin T and C-reactive protein are strongly related to the long-term risk of death from cardiac causes. These markers are independent risk factors, and their effects are additive with respect to each other and other clinical indicators of risk.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11036119     DOI: 10.1056/NEJM200010193431602

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  190 in total

Review 1.  Role of infectious and immune factors in coronary and cerebrovascular arteriosclerosis.

Authors:  Claudia Stöllberger; Josef Finsterer
Journal:  Clin Diagn Lab Immunol       Date:  2002-03

2.  Multicentre evaluation of the diagnostic value of cardiac troponin T, CK-MB mass, and myoglobin for assessing patients with suspected acute coronary syndromes in routine clinical practice.

Authors:  P O Collinson; P J Stubbs; A-C Kessler
Journal:  Heart       Date:  2003-03       Impact factor: 5.994

3.  Sources of variability in measurements of cardiac troponin T in a community-based sample: the atherosclerosis risk in communities study.

Authors:  Sunil K Agarwal; Christy L Avery; Christie M Ballantyne; Diane Catellier; Vijay Nambi; Justin Saunders; A Richey Sharrett; Josef Coresh; Gerardo Heiss; Ron C Hoogeveen
Journal:  Clin Chem       Date:  2011-04-25       Impact factor: 8.327

Review 4.  New biomarkers in the risk stratification of patients with suspected acute myocardial infarction.

Authors:  Bret A Rogers; L Kristin Newby
Journal:  Curr Cardiol Rep       Date:  2002-07       Impact factor: 2.931

5.  C reactive protein for risk stratification in acute coronary syndromes? Verdict: unproven.

Authors:  S Kennon; A D Timmis; R Whitbourn; C Knight
Journal:  Heart       Date:  2003-11       Impact factor: 5.994

Review 6.  Management of acute coronary syndromes: an update.

Authors:  Keith A A Fox
Journal:  Heart       Date:  2004-06       Impact factor: 5.994

Review 7.  Inflammatory and oxidative markers in atherosclerosis: relationship to outcome.

Authors:  Mehdi H Shishehbor; Stanley L Hazen
Journal:  Curr Atheroscler Rep       Date:  2004-05       Impact factor: 5.113

8.  A critical review of clinical trials for low-molecular-weight heparin therapy in unstable coronary artery disease.

Authors:  S Husted; R Becker; A Kher
Journal:  Clin Cardiol       Date:  2001-07       Impact factor: 2.882

9.  Rheumatoid arthritis, periodontal disease and coronary artery disease.

Authors:  S Abou-Raya; A Abou-Raya; A Naim; H Abuelkheir
Journal:  Clin Rheumatol       Date:  2007-08-29       Impact factor: 2.980

10.  Inflammation a possible link between economical stress and coronary heart disease.

Authors:  Katalin Gémes; Staffan Ahnve; Imre Janszky
Journal:  Eur J Epidemiol       Date:  2007-11-06       Impact factor: 8.082

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.